
Accuray (ARAY) Stock Forecast & Price Target
Accuray (ARAY) Analyst Ratings
Bulls say
Accuray is supported by a transformation plan expected to improve operating profitability by about $25M on an annualized basis, with $10M of cost and margin improvements already recognized through F3Q and roughly $12M reiterated for FY26. The company also expects restructuring charges to decline sequentially, and its initiatives to be fully implemented by the end of FY26, which should help translate its precision-radiation franchise into better earnings power. Despite current headwinds around commercial execution and visibility, the underlying CyberKnife platform, backlog conversion potential, and exposure to capital spending recovery provide a credible path to improved fundamentals.
Bears say
Accuray is burdened by weakening fundamentals as F3Q revenue fell 7% year over year to $104.8M, product revenue missed expectations at $49.7M, gross orders came in at $48.5M, and adj. EBITDA of $3.8M also fell short, underscoring deteriorating commercial execution and limited operating leverage. The company’s FY2026 guidance withdrawal, tied to geopolitical uncertainty in the Middle East and ongoing headwinds in China, highlights poor visibility, delayed shipments, and revenue that appears increasingly exposed to forces outside management’s control. Even with cost-cutting ahead of schedule and valuation below 1x NTM EV/Sales, declining revenue, thin profitability, and no clear evidence of a turnaround justify a negative outlook.
This aggregate rating is based on analysts' research of Accuray and is not a guaranteed prediction by Public.com or investment advice.
Accuray (ARAY) Analyst Forecast & Price Prediction
Start investing in Accuray (ARAY)
Order type
Buy in
Order amount
Est. shares
0 shares